Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Anderson

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Human Molecular Genetics|November 1, 1993
Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysisM R Passos-Bueno, J R Oliveira, E Bakker, et al.
The Journal of Clinical Investigation|August 1, 1993
Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophinK Matsumura, F M Tomé, V Ionasescu, et al.
Journal of the American College of Cardiology|August 31, 2001
Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experienceM Singh, G S Reeder, E M Ohman, et al.
Cell|August 26, 1994
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyS L Roberds, F Leturcq, V Allamand, et al.
The EMBO Journal|June 1, 1992
Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cellsT Ishiji, M J Lace, S Parkkinen, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1994
Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiencyN B Romero, F M Tomé, F Leturcq, et al.
Journal of the American College of Cardiology|October 13, 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventionsR D Anderson, E M Ohman, D R Holmes, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Coronary atheroma burden predicts flow reserve in women with ischemia and nonobstructive coronary artery diseaseC Pacheco, A AlBadri, R D Anderson, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
The American Journal of Cardiology|July 13, 2001
Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trialR J Lederman, A N Tenaglia, R D Anderson, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Human Molecular Genetics|November 1, 1993
Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysisM R Passos-Bueno, J R Oliveira, E Bakker, et al.
The Journal of Clinical Investigation|August 1, 1993
Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophinK Matsumura, F M Tomé, V Ionasescu, et al.
Journal of the American College of Cardiology|August 31, 2001
Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experienceM Singh, G S Reeder, E M Ohman, et al.
Cell|August 26, 1994
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyS L Roberds, F Leturcq, V Allamand, et al.
The EMBO Journal|June 1, 1992
Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cellsT Ishiji, M J Lace, S Parkkinen, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1994
Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiencyN B Romero, F M Tomé, F Leturcq, et al.
Journal of the American College of Cardiology|October 13, 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventionsR D Anderson, E M Ohman, D R Holmes, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Coronary atheroma burden predicts flow reserve in women with ischemia and nonobstructive coronary artery diseaseC Pacheco, A AlBadri, R D Anderson, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
The American Journal of Cardiology|July 13, 2001
Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trialR J Lederman, A N Tenaglia, R D Anderson, et al.
Pageof 10